Effect of galcanezumab on migraine headache days in women with menstrual migraine: A post hoc analysis

被引：0
作者：
MacGregor, E. [1 ]
Okonkwo, R. [2 ]
Fernandes, M. F. [2 ]
Rettiganti, M. [2 ]
Detke, H. [2 ]
Pavlovic, J. M. [3 ]
机构：
[1] St Bartholomews Hosp, London, England
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Montefiore Headache Ctr, Albert Einstein Coll Med, Bronx, NY USA
来源：
HEADACHE | 2021年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IOR-01
引用
收藏
页码：87 / 88
页数：2
相关论文
共 50 条
  • [41] Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis
    Pozo-Rosich, Patricia
    Samaan, Karen H.
    Schwedt, Todd J.
    Nicholson, Robert A.
    Rettiganti, Mallikarjuna
    Pearlman, Eric M.
    ADVANCES IN THERAPY, 2021, 38 (06) : 3154 - 3165
  • [42] Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis
    Patricia Pozo-Rosich
    Karen H. Samaan
    Todd J. Schwedt
    Robert A. Nicholson
    Mallikarjuna Rettiganti
    Eric M. Pearlman
    Advances in Therapy, 2021, 38 : 3154 - 3165
  • [43] Incidence of migraine across the menstrual cycle in women with difficult to-treat menstrual migraine
    MacGregor, A. A.
    Campbell, John
    Ryder, Kevin
    Schuler, Kristine W.
    DeJong, Bert
    NEUROLOGY, 2008, 70 (11) : A354 - A354
  • [44] EHMTI-0230. Characteristics of menstrual and nonmenstrual migraine attacks in women with menstrual migraine
    KG Vetvik
    EA MacGregor
    J Šaltyté Benth
    AC Lundqvist
    MB Russell
    The Journal of Headache and Pain, 2014, 15
  • [45] Menstrual versus non-menstrual attacks of migraine without aura in women with and without menstrual migraine
    Vetvik, Kjersti Grotta
    Benth, Jurate Saltyte
    MacGregor, E. Anne
    Lundqvist, Christofer
    Russell, Michael Bjorn
    CEPHALALGIA, 2015, 35 (14) : 1261 - 1268
  • [46] Correction to: Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache
    Lesley J. Scott
    Drugs, 2020, 80 : 1379 - 1379
  • [47] Cervicogenic Headache Responsive to Galcanezumab in Patients With Comorbid Migraine: A Case Series
    Mehta, D.
    Watson, J.
    Kissoon, N.
    HEADACHE, 2020, 60 : 7 - 7
  • [48] Comparing Migraine Headache Index versus Monthly Migraine Days after Headache Surgery: A Systematic Review and Meta-Analysis
    Ormseth, Benjamin H.
    Elhawary, Hassan
    Huayllani, Maria T.
    Weber, Kevin D.
    Blake, Pamela
    Janis, Jeffrey E.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 153 (06) : 1201e - 1211e
  • [49] Beyond migraine headache day reduction: Clinically meaningful improvement in disability (MIDAS score) in the absence of greater than 50% reductions in monthly migraine days with galcanezumab
    Vargas, Bert
    Starling, Amaal
    Nicholson, Robert
    Polavieja, Pepa
    Katsarava, Zaza
    Viktrup, Lars
    Vincent, Maurice
    Lipton, Richard
    NEUROLOGY, 2023, 100 (17)
  • [50] Erenumab prevents the occurrence of migraine attacks and not just migraine days: Post-hoc analyses of a phase III study
    Diener, Hans-Christoph
    Ashina, Messoud
    Ritter, Shannon
    Lima, Gabriel Paiva Da Silva
    Rasmussen, Soeren
    Zielman, Ronald
    Tfelt-Hansen, Peer
    CEPHALALGIA, 2021, 41 (11-12) : 1262 - 1267
12345